Evaluation for NCI Surgery Branch Clinical Research Protocols
Recruiting
7,000 enrolled
Harvesting Cells for Experimental Cancer Treatments
Enrolling by invitation
7,000 enrolled
Esophageal Cancer Genetics Studies
Completed
7,705 enrolled
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Phase 1 Recruiting
100 enrolled
Nutrition Intervention Trials in Linxian Follow-up Study
Completed
32,902 enrolled
Mobile Sensor Technologies to Assess General Symptomology of People With Cancer
Completed
49 enrolled
A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy
Phase 1 Completed
17 enrolled
A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies
Phase 2 Withdrawn
A Study of Patients Receiving High-Dose Rate Brachytherapy
Phase 2 Completed
43 enrolled 13 charts
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
Phase 1 Completed
29 enrolled
Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer
Phase 1 Completed
58 enrolled 17 charts
Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer
Phase 1/2 Withdrawn
Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
Phase 1 Completed
Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors
Phase 1 Completed
Vaccine Therapy in Treating Patients With Metastatic Cancer
Phase 1 Completed
Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver
Phase 2 Completed
Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas
Phase 2 Completed
A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal Cancer
Phase 1/2 Completed
34 enrolled 18 charts
Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors
Phase 1/2 Completed
40 enrolled 37 charts
Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy
Terminated
98 enrolled
The Second Multicenter Hemophilia Cohort Study
Completed
2,565 enrolled
The Natural History of Solid Organ Cancer Stem Cells (SOCSC)
Terminated
190 enrolled
Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery
Phase 2 Terminated
4 enrolled 6 charts
PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer
Phase 1/2 Completed
51 enrolled 20 charts
A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies
Phase 1 Completed
60 enrolled
Cancer Vaccine Targeting Brachyury Protein in Tumors
Phase 1 Completed
34 enrolled 19 charts
Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors
Phase 1 Completed
12 enrolled
Tabectedin to Treat Children and Adolescents With Cancer
Phase 1 Completed
12 enrolled
Care of Cancer Patients With Bowel Injury Caused by Radiation Therapy to the Pelvis
Phase NA Completed
250 enrolled
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Phase 2 Unknown
60 enrolled
Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer
Unknown
96 enrolled
BCX-1777 in Treating Patients With Refractory Cancer
Phase 1 Completed
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
Phase 1 Completed
24 enrolled
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Completed
75 enrolled
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer
Phase 4 Unknown
58 enrolled
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum
Phase 1 Completed
PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer
Phase 1 Completed
Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modalities
Phase 2 Completed
200 enrolled
Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas
Phase 2 Completed
50 enrolled